The Pfizer Global Supply (PGS) site in Puurs, Belgium, specializing in aseptic production and packaging, is one of the largest production and packaging sites in the worldwide Pfizer network

Each year, colleagues in Puurs produce more than 400 million doses of injectable vaccines and medicines in various formats including ampoules, vials, plastic bottles, syringes and cartridges for pens. These medicines are destined for patients in more than 170 countries worldwide and almost one-third of the total production in Puurs is directed to developing countries through Pfizer’s collaboration with world aid organizations such as UNICEF, WHO and GAVI.

​​​​​​The production of the Pfizer-BioNTech COVID-19 vaccine is another example of the site’s strategic importance to PGS, Pfizer and patients. Upon the initial announcement in May that Pfizer Puurs could be involved in COVID-19 vaccine production, the site immediately began preparing: investing in infrastructure, improving existing production facilities and adding new production lines. Since then, site colleagues have been moving, as they say, “at the speed of science” to manufacture doses of our COVID-19 vaccine for all markets outside the U.S.

​​​​​​The site is also known for its focus on renewable energy. It utilizes two wind turbines, solar panels and a cogeneration plant for its power and heat supply. Per year, Puurs colleagues travel more than two million kilometers commuting by bike.

​​​​​​The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see EUA Fact Sheet at www.cvdvaccine.com.